Home
CNTB
CNTB News

Latest Connect Biopharma Holdings Limited (CNTB) News on May 14, 2025

Connect Biopharma Initiates Phase 2 Seabreeze STAT COPD Study Evaluating Rademikibart for the Treatment of Acute Exacerbations in COPD

GlobeNewswire

4 hours ago

Connect Biopharma Initiates Phase 2 Seabreeze STAT COPD Study Evaluating Rademikibart for the Treatment of Acute Exacerbations in COPD

Connect Biopharma begins Phase II trial of drug for acute exacerbations in asthma

Clinical Trials Arena

8 hours ago

Connect Biopharma begins Phase II trial of drug for acute exacerbations in asthma

Connect Biopharma Initiates Phase 2 Seabreeze STAT Asthma Study Evaluating Rademikibart for the Treatment of Acute Exacerbations in Asthma

GlobeNewswire

a day ago

Connect Biopharma Initiates Phase 2 Seabreeze STAT Asthma Study Evaluating Rademikibart for the Treatment of Acute Exacerbations in Asthma

Connect Biopharma Announces Multiple Presentations at the American Thoracic Society (ATS) 2025 International Conference

GlobeNewswire

20 days ago

Connect Biopharma Announces Multiple Presentations at the American Thoracic Society (ATS) 2025 International Conference

ACCESS Newswire

a month ago

Bullfrog AI and Connect Biopharma Interviews to Air on the RedChip Small Stocks, Big Money(TM) Show on Bloomberg TV

Talkspace And 2 Other Promising Penny Stocks

Simply Wall St.

a month ago

Talkspace And 2 Other Promising Penny Stocks

Connect Biopharma Announces Positive Type C Meeting with the FDA for Rademikibart

GlobeNewswire

a month ago

Connect Biopharma Announces Positive Type C Meeting with the FDA for Rademikibart

Connect Biopharma Announces Publication of Positive Data from Global Phase 2 Trial of Rademikibart in Patients with Moderate-to-Severe Uncontrolled Asthma

GlobeNewswire

a month ago

Connect Biopharma Announces Publication of Positive Data from Global Phase 2 Trial of Rademikibart in Patients with Moderate-to-Severe Uncontrolled Asthma

Connect Biopharma Reports 2024 Full-Year Financial Results and Provides Business Update

GlobeNewswire

a month ago

Connect Biopharma Reports 2024 Full-Year Financial Results and Provides Business Update

MT Newswires

2 months ago

Connect Biopharma Receives Noncompliance Notice From Nasdaq

Connect Biopharma Announces Receipt of Nasdaq Deficiency Notice Regarding Minimum Bid Price Requirement

GlobeNewswire

2 months ago

Connect Biopharma Announces Receipt of Nasdaq Deficiency Notice Regarding Minimum Bid Price Requirement

Connect Biopharma to Present at Two Upcoming Investor Conferences

GlobeNewswire

2 months ago

Connect Biopharma to Present at Two Upcoming Investor Conferences

Connect Biopharma Holdings And Two Other Promising Penny Stocks To Watch

Simply Wall St.

3 months ago

Connect Biopharma Holdings And Two Other Promising Penny Stocks To Watch

3 US Penny Stocks With Market Caps Under $400M To Consider

Simply Wall St.

4 months ago

3 US Penny Stocks With Market Caps Under $400M To Consider

US Penny Stocks To Monitor In November 2024

Simply Wall St.

6 months ago

US Penny Stocks To Monitor In November 2024

Attovia Therapeutics Appoints Chief Financial Officer

GlobeNewswire

7 months ago

Attovia Therapeutics Appoints Chief Financial Officer

Connect Biopharma to Participate in the Cantor Fitzgerald Global Healthcare Conference 2024

GlobeNewswire

8 months ago

Connect Biopharma to Participate in the Cantor Fitzgerald Global Healthcare Conference 2024

Connect Biopharma Reports First Half 2024 Financial Results and Provides Business Update

GlobeNewswire

8 months ago

Connect Biopharma Reports First Half 2024 Financial Results and Provides Business Update

Connect Biopharma Holdings (NASDAQ:CNTB) Is In A Good Position To Deliver On Growth Plans

Simply Wall St.

9 months ago

Connect Biopharma Holdings (NASDAQ:CNTB) Is In A Good Position To Deliver On Growth Plans

Connect Biopharma to Participate in the Leerink Partners I&I and Metabolism Therapeutics Forum

GlobeNewswire

10 months ago

Connect Biopharma to Participate in the Leerink Partners I&I and Metabolism Therapeutics Forum

Connect Biopharma Announces Inducement Grants under Nasdaq Listing Rule 5635(c)(4)

GlobeNewswire

a year ago

Connect Biopharma Announces Inducement Grants under Nasdaq Listing Rule 5635(c)(4)

MT Newswires

a year ago

Connect Biopharma Names New Chief Executive, Chair

Connect Biopharma Announces New Leadership and Chair of the Board of Directors

GlobeNewswire

a year ago

Connect Biopharma Announces New Leadership and Chair of the Board of Directors

Connect Biopharma Holdings Limited's (NASDAQ:CNTB) top owners are private equity firms with 39% stake, while 22% is held by insiders

Simply Wall St.

a year ago

Connect Biopharma Holdings Limited's (NASDAQ:CNTB) top owners are private equity firms with 39% stake, while 22% is held by insiders

Connect Biopharma Presents Late-Breaking Abstract at the American Thoracic Society 2024 International Conference on the Positive Rademikibart Data from its Global Phase 2b in Patients with Moderate-to-Severe Asthma

GlobeNewswire

a year ago

Connect Biopharma Presents Late-Breaking Abstract at the American Thoracic Society 2024 International Conference on the Positive Rademikibart Data from its Global Phase 2b in Patients with Moderate-to-Severe Asthma

Connect Biopharma to Present a Late-Breaking Abstract at the American Thoracic Society (ATS) 2024 International Conference on the Positive Results from the Global Phase 2b Trial of Rademikibart in Patients with Moderate-to-Severe Asthma

GlobeNewswire

a year ago

Connect Biopharma to Present a Late-Breaking Abstract at the American Thoracic Society (ATS) 2024 International Conference on the Positive Results from the Global Phase 2b Trial of Rademikibart in Patients with Moderate-to-Severe Asthma

Stonegate Healthcare Partners Updates Report on Transformative Therapies for Pruritus Management

Newsfile

a year ago

Stonegate Healthcare Partners Updates Report on Transformative Therapies for Pruritus Management

Connect Biopharma Reports Full Year 2023 Financial Results and Provides Business Update

GlobeNewswire

a year ago

Connect Biopharma Reports Full Year 2023 Financial Results and Provides Business Update

Connect Biopharma to Participate in H.C. Wainwright 2ⁿᵈ Annual Autoimmune & Inflammatory Disease Virtual Conference

GlobeNewswire

a year ago

Connect Biopharma to Participate in H.C. Wainwright 2ⁿᵈ Annual Autoimmune & Inflammatory Disease Virtual Conference

Connect Biopharma Appoints Industry Veteran James Huang to Board of Directors

GlobeNewswire

a year ago

Connect Biopharma Appoints Industry Veteran James Huang to Board of Directors

The Whac-A-Mole reality of autonomous trucking regulations

FreightWaves

a year ago

The Whac-A-Mole reality of autonomous trucking regulations

FinWise Bancorp Reports Fourth Quarter and Full Year 2023 Results

GlobeNewswire

a year ago

FinWise Bancorp Reports Fourth Quarter and Full Year 2023 Results

Will Connect Biopharma Holdings (NASDAQ:CNTB) Spend Its Cash Wisely?

Simply Wall St.

a year ago

Will Connect Biopharma Holdings (NASDAQ:CNTB) Spend Its Cash Wisely?

Emeren Group Announces Preliminary 2023 Financials and 2024 Outlook

PR Newswire

a year ago

Emeren Group Announces Preliminary 2023 Financials and 2024 Outlook

Fidelity D & D Bancorp, Inc. Reports 2023 Financial Results

GlobeNewswire

a year ago

Fidelity D & D Bancorp, Inc. Reports 2023 Financial Results

Newsfile

a year ago

Alternus Clean Energy Inc.: Invitation to The Microcap Conference

Alternus Clean Energy to Present at The Microcap Conference

GlobeNewswire

a year ago

Alternus Clean Energy to Present at The Microcap Conference

Zacks Small Cap Research

a year ago

AIXI: Initiating Coverage – The AI hype cycle subsides but opportunities and challenges lie ahead in 2024

Is It Time To Consider Buying Culp, Inc. (NYSE:CULP)?

Simply Wall St.

a year ago

Is It Time To Consider Buying Culp, Inc. (NYSE:CULP)?

Zoomcar Announces the Appointment of Adarsh Menon as President

GlobeNewswire

a year ago

Zoomcar Announces the Appointment of Adarsh Menon as President

Alternus Clean Energy Retires $10 Million of Convertible Debt

GlobeNewswire

a year ago

Alternus Clean Energy Retires $10 Million of Convertible Debt

Eyenovia Re-Acquires Development and Commercialization Rights to MicroPine in the U.S. and Canada

GlobeNewswire

a year ago

Eyenovia Re-Acquires Development and Commercialization Rights to MicroPine in the U.S. and Canada

Will Seer (NASDAQ:SEER) Spend Its Cash Wisely?

Simply Wall St.

a year ago

Will Seer (NASDAQ:SEER) Spend Its Cash Wisely?

4 Best Breakout Stocks to Buy for Stellar Returns

Zacks

a year ago

4 Best Breakout Stocks to Buy for Stellar Returns

Culp, Inc. to Participate in Water Tower Research Furniture/Furnishings Virtual Conference 2024

Business Wire

a year ago

Culp, Inc. to Participate in Water Tower Research Furniture/Furnishings Virtual Conference 2024

Xiao-I and eRoad Forge Strategic Partnership to Drive Commercialization Through Xiao-I's Hua Zang Ecosystem

ACCESSWIRE

a year ago

Xiao-I and eRoad Forge Strategic Partnership to Drive Commercialization Through Xiao-I's Hua Zang Ecosystem

Alternus Clean Energy to Participate in Water Tower Research Fireside Chat Series

GlobeNewswire

a year ago

Alternus Clean Energy to Participate in Water Tower Research Fireside Chat Series

Emeren Group Successfully Acquired 10.76 MWh Energy Storage Portfolio in China, Entering Virtual Power Plant Market

PR Newswire

a year ago

Emeren Group Successfully Acquired 10.76 MWh Energy Storage Portfolio in China, Entering Virtual Power Plant Market

PetMeds® Announces new Chairman of the Board

PR Newswire

a year ago

PetMeds® Announces new Chairman of the Board

Valens Semiconductor and Intel Foundry Services Announce Strategic Relationship for Next Generation A-PHY Product

PR Newswire

a year ago

Valens Semiconductor and Intel Foundry Services Announce Strategic Relationship for Next Generation A-PHY Product

iTeos Announces 2024 Strategic Priorities and Anticipated Milestones

GlobeNewswire

a year ago

iTeos Announces 2024 Strategic Priorities and Anticipated Milestones

Argo Blockchain PLC Announces £7.8 million ($9.9 million) Placing

ACCESSWIRE

a year ago

Argo Blockchain PLC Announces £7.8 million ($9.9 million) Placing

Mesoblast Limited (MESO) Loses -5.45% in 4 Weeks, Here's Why a Trend Reversal May be Around the Corner

Zacks

a year ago

Mesoblast Limited (MESO) Loses -5.45% in 4 Weeks, Here's Why a Trend Reversal May be Around the Corner

Novo Nordisk enters research partnerships with biotech firms

Yahoo Finance Video

a year ago

Novo Nordisk enters research partnerships with biotech firms

AC Immune (ACIU) Upgraded to Buy: Here's Why

Zacks

a year ago

AC Immune (ACIU) Upgraded to Buy: Here's Why

G1 Therapeutics to Participate in the 42nd Annual J.P. Morgan Healthcare Conference

GlobeNewswire

a year ago

G1 Therapeutics to Participate in the 42nd Annual J.P. Morgan Healthcare Conference

‘Go Head First Into 2024’: Talkspace Therapists Provide Simple, Actionable Steps For Prioritizing Mental Health This Year

Business Wire

a year ago

‘Go Head First Into 2024’: Talkspace Therapists Provide Simple, Actionable Steps For Prioritizing Mental Health This Year

RADCOM to Present at the 26th Annual Needham Growth Conference on Thursday, January 18

PR Newswire

a year ago

RADCOM to Present at the 26th Annual Needham Growth Conference on Thursday, January 18

Actinium Announces Acceptance of Five Abstracts for Presentation at the 2024 Tandem Meetings | Transplantation & Cellular Therapy Meetings of ASTCT® and CIBMTR®

PR Newswire

a year ago

Actinium Announces Acceptance of Five Abstracts for Presentation at the 2024 Tandem Meetings | Transplantation & Cellular Therapy Meetings of ASTCT® and CIBMTR®

High Tide Welcomes Doubling of Ontario Retail Cannabis Store Cap

PR Newswire

a year ago

High Tide Welcomes Doubling of Ontario Retail Cannabis Store Cap

High Tide Recaps Key Milestones of 2023

CNW Group

a year ago

High Tide Recaps Key Milestones of 2023

GlobeNewswire

a year ago

Zoomcar, the World’s Largest Emerging Market Focused Car Sharing Platform, Announces Completion of its Business Combination with Innovative International Acquisition Corporation (IOAC) and Anticipated Nasdaq Listing

High Tide to Open First Canna Cabana in Mississauga, Ontario

CNW Group

a year ago

High Tide to Open First Canna Cabana in Mississauga, Ontario

Emeren Group Purchases an 86 MWp Solar Portfolio in Spain

PR Newswire

a year ago

Emeren Group Purchases an 86 MWp Solar Portfolio in Spain

Should Value Investors Buy KNOT Offshore Partners (KNOP) Stock?

Zacks

a year ago

Should Value Investors Buy KNOT Offshore Partners (KNOP) Stock?

Are Medical Stocks Lagging Bausch Health (BHC) This Year?

Zacks

a year ago

Are Medical Stocks Lagging Bausch Health (BHC) This Year?

PR Newswire

a year ago

Energy Services of America Announces Financial Results for the Fiscal Year Ended September 30, 2023

7 Promising Penny Stocks With the Potential to Defy Expectations

InvestorPlace

a year ago

7 Promising Penny Stocks With the Potential to Defy Expectations

Zacks Small Cap Research

a year ago

XFOR: Update on Phase 2 CN Trial at ASH 2023

MainStreet Bank Promotes Tom Floyd to Executive Vice President

PR Newswire

a year ago

MainStreet Bank Promotes Tom Floyd to Executive Vice President

ESSA Bancorp's (NASDAQ:ESSA) Dividend Will Be $0.15

Simply Wall St.

a year ago

ESSA Bancorp's (NASDAQ:ESSA) Dividend Will Be $0.15

Seanergy Maritime Holdings (NASDAQ:SHIP) Has Announced A Dividend Of $0.025

Simply Wall St.

a year ago

Seanergy Maritime Holdings (NASDAQ:SHIP) Has Announced A Dividend Of $0.025

Connect Biopharma Announces Positive Rademikibart Global Phase 2b Topline Results in Adult Patients with Moderate-to-Severe Persistent Asthma

GlobeNewswire

a year ago

Connect Biopharma Announces Positive Rademikibart Global Phase 2b Topline Results in Adult Patients with Moderate-to-Severe Persistent Asthma

Connect Biopharma to Announce Top-Line Data from the Global Phase 2b Trial of Rademikibart in Patients with Moderate-to-Severe Asthma on December 12, 2023

GlobeNewswire

a year ago

Connect Biopharma to Announce Top-Line Data from the Global Phase 2b Trial of Rademikibart in Patients with Moderate-to-Severe Asthma on December 12, 2023

Butterfly Network to Present at the 42nd Annual J.P. Morgan Healthcare Conference

Business Wire

a year ago

Butterfly Network to Present at the 42nd Annual J.P. Morgan Healthcare Conference

Does The Market Have A Low Tolerance For DHI Group, Inc.'s (NYSE:DHX) Mixed Fundamentals?

Simply Wall St.

a year ago

Does The Market Have A Low Tolerance For DHI Group, Inc.'s (NYSE:DHX) Mixed Fundamentals?

X4 Pharmaceuticals Announces Presentation of Additional Data from Mavorixafor Phase 2 Trial in Chronic Neutropenia at ASH 2023

GlobeNewswire

a year ago

X4 Pharmaceuticals Announces Presentation of Additional Data from Mavorixafor Phase 2 Trial in Chronic Neutropenia at ASH 2023

TEN Ltd. Lloyd’s List Tanker Company of the Year for 2023

GlobeNewswire

a year ago

TEN Ltd. Lloyd’s List Tanker Company of the Year for 2023

Vera Bradley (VRA) Beats Q3 Earnings Estimates

Zacks

a year ago

Vera Bradley (VRA) Beats Q3 Earnings Estimates

Shareholders in Upland Software (NASDAQ:UPLD) are in the red if they invested three years ago

Simply Wall St.

a year ago

Shareholders in Upland Software (NASDAQ:UPLD) are in the red if they invested three years ago

Stonegate Healthcare Partners Releases Report on Transformative Therapies for Pruritus Management

Newsfile

a year ago

Stonegate Healthcare Partners Releases Report on Transformative Therapies for Pruritus Management

Is Connect Biopharma Holdings (CNTB) Stock Outpacing Its Medical Peers This Year?

Zacks

a year ago

Is Connect Biopharma Holdings (CNTB) Stock Outpacing Its Medical Peers This Year?

After Plunging -17.65% in 4 Weeks, Here's Why the Trend Might Reverse for InflaRx N.V. (IFRX)

Zacks

a year ago

After Plunging -17.65% in 4 Weeks, Here's Why the Trend Might Reverse for InflaRx N.V. (IFRX)

Townsquare To Participate In Upcoming Investor Conferences

GlobeNewswire

a year ago

Townsquare To Participate In Upcoming Investor Conferences

InvestorPlace

a year ago

Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Tuesday

Connect Biopharma and Simcere Announce Exclusive Licensing and Collaboration Agreement in Greater China

GlobeNewswire

a year ago

Connect Biopharma and Simcere Announce Exclusive Licensing and Collaboration Agreement in Greater China

Alpha Tau Submits to Japanese PMDA for Pre-Market Approval of Alpha DaRT in Patients with Recurrent Head and Neck Cancer

GlobeNewswire

a year ago

Alpha Tau Submits to Japanese PMDA for Pre-Market Approval of Alpha DaRT in Patients with Recurrent Head and Neck Cancer

PR Newswire

a year ago

ENERGY SERVICES OF AMERICA ANNOUNCES ANNUAL DIVIDEND

Universal Declares Regular and Special Cash Dividends

Business Wire

a year ago

Universal Declares Regular and Special Cash Dividends

Successful Operation of a Large-scale Energy Storage System by ADS-TEC Energy in Switzerland

Business Wire

a year ago

Successful Operation of a Large-scale Energy Storage System by ADS-TEC Energy in Switzerland

Sidoti Events, LLC’s Virtual November Micro-Cap Conference

ACCESSWIRE

2 years ago

Sidoti Events, LLC’s Virtual November Micro-Cap Conference

Empire Petroleum Announces Results for Third Quarter 2023

Business Wire

2 years ago

Empire Petroleum Announces Results for Third Quarter 2023

Thomson Reuters StreetEvents

2 years ago

Q3 2023 Lineage Cell Therapeutics Inc Earnings Call

Precigen Reports Third Quarter 2023 Financial Results and Progress of Clinical Programs

PR Newswire

2 years ago

Precigen Reports Third Quarter 2023 Financial Results and Progress of Clinical Programs

Lineage Cell Therapeutics Reports Third Quarter 2023 Financial Results and Provides Business Update

Business Wire

2 years ago

Lineage Cell Therapeutics Reports Third Quarter 2023 Financial Results and Provides Business Update

Atossa Therapeutics Appoints Financial Executive Jonathan Finn to its Board of Directors

GlobeNewswire

2 years ago

Atossa Therapeutics Appoints Financial Executive Jonathan Finn to its Board of Directors

OptiNose Inc (OPTN) Reports Q3 2023 Financial Results with Improved Operating Efficiency

GuruFocus.com

2 years ago

OptiNose Inc (OPTN) Reports Q3 2023 Financial Results with Improved Operating Efficiency

Sharecare announces third quarter 2023 financial results and operational highlights

GlobeNewswire

2 years ago

Sharecare announces third quarter 2023 financial results and operational highlights

GuruFocus.com

2 years ago

Great Elm Group Inc Reports Substantial Revenue Growth and Net Income Turnaround in Q1 Fiscal 2024

Clarus (NASDAQ:CLAR) Has Affirmed Its Dividend Of $0.025

Simply Wall St.

2 years ago

Clarus (NASDAQ:CLAR) Has Affirmed Its Dividend Of $0.025

Share on Social Networks: